The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 8604014 B1

PDF
Full Text
Expired
Date of Patent:
Dec. 10, 2013

Filed:

May. 17, 2011
Applicants:

Marcia Belvin, South San Francisco, CA (US);

Lori Friedman, South San Francisco, CA (US);

Klaus Hoeflich, South San Francisco, CA (US);

Deepak Sampath, South San Francisco, CA (US);

Ulka Vijapurkar, South San Francisco, CA (US);

Jeffrey Wallin, South San Francisco, CA (US);

Leisa Johnson, South San Francisco, CA (US);

Mallika Singh, South San Francisco, CA (US);

Sonal Patel, Basel, GB;

Inventors:

Marcia Belvin, South San Francisco, CA (US);

Lori Friedman, South San Francisco, CA (US);

Klaus Hoeflich, South San Francisco, CA (US);

Deepak Sampath, South San Francisco, CA (US);

Ulka Vijapurkar, South San Francisco, CA (US);

Jeffrey Wallin, South San Francisco, CA (US);

Leisa Johnson, South San Francisco, CA (US);

Mallika Singh, South San Francisco, CA (US);

Sonal Patel, Basel, GB;

Assignees:

Genentech, Inc., South San Francisco, CA (US);

F. Hoffmann-La Roche AG, Basel, CH;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/33 (2006.01); G01N 33/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

Combinations of PI3K inhibitor compounds having Formulas I and II and chemotherapeutic agents, including stereoisomers, geometric isomers, tautomers, metabolites and pharmaceutically acceptable salts thereof, are useful for treating hyperproliferative disorders such as cancer. Methods of using such combinations for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions, are disclosed.


Find Patent Forward Citations

Quick Actions:

Belvin, Marcia. (2013). Combinations of phosphoinositide 3-kinase inhibitor compounds chemotherapeutic agents, and methods of use (U.S. Patent No. 8604014). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/8604014

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…